We deliver innovative biomarker solutions to meet and exceed your needs. 


Clinical research benefits from innovative biomarker solutions utilizing a broad range of technology, methodologies and matrices to test for biomarkers that are crucial for the selection of the right treatment strategy for the patient.  A comprehensive biomarker approach is important to ensure both the clinical and commercial success of the drug candidate in an efficient and cost effective manner.

Cambridge Biomedical has significant experience working with large and small molecules, biologics, vaccines and biomarkers to support pharmaceutical, biotech and in-vitro diagnostic (IVD) manufacturing companies across the development cycle.

Our areas of expertise include:

Leading with science, we deliver biomarker solutions with quality and exceptional service to meet and exceed your needs for clinical research and testing.

Cambridge Biomedical offer established expertise in assay development, assay validation, and specimen analysis for biomarkers and bioanalytical assays.  We provide a diverse range of simple to highly complex assays for both routine and esoteric use, across a wide range of technologies. We also accommodate study sizes with low, medium, or high volume sample testing requirements.

Our laboratory is CLIA certified, CAP accredited, and GLP/GCLP compliant.  


Speak to a biomarker expert today.